Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index; 17 of the 52 sources its claims cite were checked for support.

Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis

Open access

Abstract

Controlling glycosylation, a critical quality attribute of biopharmaceuticals such as monoclonal antibodies, is essential, as it significantly influences biological activity and therapeutic efficacy. Although numerous studies have examined the impact of process parameters (PP, e.g. temperature, pH, dissolved oxygen) on glycosylation, the lack of standardized reporting makes cross-study comparisons challenging and prevents clear conclusions. Here, we systematically reviewed the literature and applied a normalized quantitative framework, the Glycan Indices approach, as a standardized quantitative criterion to evaluate the impact of process parameters on glycoform distribution in IgG-producing CHO cell systems objectively. This methodology enabled the integration and reinterpretation of large, heterogeneous datasets, validating some well-known patterns while providing novel perspectives about process parameters. Our analysis revealed that PP manipulations of pH, dissolved oxygen or CO2 partial pressure rarely resulted in meaningful shifts in glycosylation, with changes <5% observed for galactose, fucose, or N-acetylneuraminic acid content. In contrast, for several cases temperature and osmolality changes notably affected galactosylation (>10%) and fucosylation (1–10%), variations that may have significant biological consequences. To our knowledge, this is the first comprehensive quantitative assessment of process parameters effects on glycosylation, showing that such influences are consistently limited, independent of CHO cell line or culture mode. Based in our observations we strongly recommend reporting both glycan distribution and glycan indices when performing glycan analysis. Dual reporting facilitates inter-study comparisons and prevents subtle shifts in sugar moieties from being masked by glycan redistribution.

Overview

CoChat Summary

TL;DR

This systematic review applies the Glycan Indices (GIx) framework to compare how process parameters affect Fc N-glycosylation of IgG produced in CHO systems. It finds that most pH, dissolved oxygen, pCO₂, and chemical-additive manipulations cause limited changes, while temperature and osmolality can produce biologically relevant shifts in galactosylation and fucosylation.

Key findings

  • Across 39 eligible articles, 32 provided sufficient data for GIx analysis, yielding 78 process-parameter manipulations. Most PP modifications, including pH, DO, pCO₂, and chemical additives, led to less than 10% deviation in GIx, with some changes below 1.5%.
  • pH, dissolved oxygen, or CO₂ partial pressure manipulations rarely produced meaningful glycosylation shifts, with changes <5% for galactose, fucose, or N-acetylneuraminic acid content.
  • Temperature and osmolality changes notably affected galactosylation (>10%) and fucosylation (1–10%); these changes may have significant biological consequences.
  • Typical mAb glycosylation ranges were FI >85%, GI 10–30%, and SI <10%. The authors recommend reporting both glycan distribution and glycan indices to enable inter-study comparisons and avoid masking subtle shifts.

Methods

  • Systematic literature review using indexed databases (Scopus, Web of Science, PubMed, Wiley Online Library, Google Scholar) for records published 2010–2024.
  • Eligible studies used CHO cells, produced IgG-type mAb or related product, reported Fc N-glycan measurements as glycoform distributions or GIx, and investigated at least one process parameter expected to influence glycosylation.
  • FI, GI, and SI were calculated following Blondeel & Aucoin; ΔGIx was defined as the absolute percentage difference between control and manipulated conditions. Data were clustered by operational parameter, perturbation type, culture mode, and CHO cell lineage. The mannose index was excluded because most articles did not report the needed data.

Limitations

  • The authors state the analysis was restricted to CHO-cell-derived mAbs; other expression systems and products were out of scope.
  • The authors state underlying studies vary in glycan reporting, often explore narrow or heterogeneous PP ranges, rarely include mechanistic read-outs, show high inter-study variability, uncommon scale-up tests, and do not routinely quantify downstream consequences such as additive carry-over or impurity profiles.
  • The authors also note that differences in culture systems and glycan analytical methods can introduce variability, and publication bias toward “positive” interventions may shape the evidence base; a dedicated analysis of methodological differences was outside the scope.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/19420862.2026.2643039

Cites

80 of 81 references verified1 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. (A). General overview of an IgG antibody structure formed by four polypeptide chains, two heavy (H) (in blue) and two light (L) (in green), joined by S-S bonds. At the N-terminus of each chain, is found the VH and VL variable domains of the H and L chains, respectively. This combination forms the antigen binding site. The conserved N297 glycosylation site located in the CH2 of each H chain is depicted in red. Here, an example of an N-glycan structure for CHO is shown. (B). Common IgG glycan motifs, with particular emphasis on the complex-type N-glycans, that are important in the production of mAbs in CHO platforms are shown. For species high-mannose, there may be high-manose type variants from M5 to M9, including M6, M7 and M8. Adapted from Carrara et al.8 Abbreviations: A, antennarity; fab, antigen binding fragment; Fc, crystallizable fragment; GlcNAc, N-acetylglucosamine; fuc, fucose; F, fucose occupancy; man, manose; M, mannose occupancy; Gal, galactose; G, galactose occupancy; NeuAc, N-acetylneuraminic acid, S, NeuAc occupancy. Created with BioRender.com.
Figure 1. (A). General overview of an IgG antibody structure formed by four polypeptide chains, two heavy (H) (in blue) and two light (L) (in green), joined by S-S bonds. At the N-terminus of each chain, is found the VH and VL variable domains of the H and L chains, respectively. This combination forms the antigen binding site. The conserved N297 glycosylation site located in the CH2 of each H chain is depicted in red. Here, an example of an N-glycan structure for CHO is shown. (B). Common IgG glycan motifs, with particular emphasis on the complex-type N-glycans, that are important in the production of mAbs in CHO platforms are shown. For species high-mannose, there may be high-manose type variants from M5 to M9, including M6, M7 and M8. Adapted from Carrara et al.8 Abbreviations: A, antennarity; fab, antigen binding fragment; Fc, crystallizable fragment; GlcNAc, N-acetylglucosamine; fuc, fucose; F, fucose occupancy; man, manose; M, mannose occupancy; Gal, galactose; G, galactose occupancy; NeuAc, N-acetylneuraminic acid, S, NeuAc occupancy. Created with BioRender.com.CC BY · PubMed Central
Figure 2. Common approaches to report the glycan analysis in literature, including the glycan distribution (A) obtained by HPLC/MS and the glycan indices calculation (B) according to the methodology proposed by Blondeel & Aucoin.26 Abbreviations: FI, fucosylation index; GI, galactosylation index; SI, sialylation index. Created with BioRender.com.
Figure 2. Common approaches to report the glycan analysis in literature, including the glycan distribution (A) obtained by HPLC/MS and the glycan indices calculation (B) according to the methodology proposed by Blondeel & Aucoin.26 Abbreviations: FI, fucosylation index; GI, galactosylation index; SI, sialylation index. Created with BioRender.com.CC BY · PubMed Central
Figure 3. Comparison of glycoforms distribution changes reported for experiments using temperature manipulation to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: culture at 37°C; manipulation: lower setpoint (A), temperature shift (B) and periodic shift (C). The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.
Figure 3. Comparison of glycoforms distribution changes reported for experiments using temperature manipulation to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: culture at 37°C; manipulation: lower setpoint (A), temperature shift (B) and periodic shift (C). The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.CC BY · PubMed Central
Figure 4. Comparison of glycoforms distribution changes reported for experiments using pH manipulation to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: culture at pH 7.0; manipulation: without pH control (A), constant higher setpoint (B), constant lower setpoint (C), shift to different setpoint (D), and oscillatory pH (E). The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.
Figure 4. Comparison of glycoforms distribution changes reported for experiments using pH manipulation to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: culture at pH 7.0; manipulation: without pH control (A), constant higher setpoint (B), constant lower setpoint (C), shift to different setpoint (D), and oscillatory pH (E). The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.CC BY · PubMed Central
Figure 5. Comparison of glycoforms distribution changes reported for experiments using DOT/antioxidants/pCO2 manipulation to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: culture at 25–30% DOT/culture at 5% pCO2; manipulation: constant higher DOT (A), constant lower DOT (B), and oscillatory DOT (C), antioxidant addition (D) and higher pCO2 setpoint (E). The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.
Figure 5. Comparison of glycoforms distribution changes reported for experiments using DOT/antioxidants/pCO2 manipulation to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: culture at 25–30% DOT/culture at 5% pCO2; manipulation: constant higher DOT (A), constant lower DOT (B), and oscillatory DOT (C), antioxidant addition (D) and higher pCO2 setpoint (E). The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.CC BY · PubMed Central
Figure 6. Comparison of glycoforms distribution changes reported for experiments using osmolality manipulation to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: natural osmolality of the culture medium; manipulation: higher osmolality. Those cases where the osmolality was not reported and only the perturbation was described are indicated in the form increase in; on the contrary, when it was measured point by point are indicated in the form increase up to. The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.
Figure 6. Comparison of glycoforms distribution changes reported for experiments using osmolality manipulation to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: natural osmolality of the culture medium; manipulation: higher osmolality. Those cases where the osmolality was not reported and only the perturbation was described are indicated in the form increase in; on the contrary, when it was measured point by point are indicated in the form increase up to. The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.CC BY · PubMed Central
Figure 7. Comparison of glycoforms distribution changes reported for experiments using supplementation of chemical compounds to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: culture medium without supplementation; manipulation: HDAC inhibitor addition (A) and qP-enhancing chemical addition (B). The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.
Figure 7. Comparison of glycoforms distribution changes reported for experiments using supplementation of chemical compounds to affect the N-linked glycosylation pattern of recombinant IgG-producing CHO cell systems. The %-change in glycoforms distribution is shown as a displacement from a starting control distribution, indicated with a ‘C’ within the respective symbol, to a final distribution following manipulation, as per the directional arrow between the points. Control: culture medium without supplementation; manipulation: HDAC inhibitor addition (A) and qP-enhancing chemical addition (B). The GIx % for galactosylation (yellow circle), sialylation (violet diamond), and fucosylation (red triangle) are represented by their respective monosaccharide symbols.CC BY · PubMed Central

Verification

Claims the paper makes

15 Valid · 6 Not valid · 24 Not checked · 75 Own results and interpretations

66 more claims · 3 with their cited sources checked

Create a free account to see all 120 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 38
  • Probably not a substantial claim. 19
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 77 references

Research works printed but not linked: 4

  1. 10.1101/GLYCOBIOLOGY.4E.9 · doi:10.1101/glycobiology.4e.9
  2. 10.1007/S10875-010-9405-6/FIGURES/2 · doi:10.1007/s10875-010-9405-6/figures/2
  3. 10.1007/S00281-012-0308-X/FIGURES/3 · doi:10.1007/s00281-012-0308-x/figures/3
  4. 10.1007/S00449-016-1693-7/TABLES/5 · doi:10.1007/s00449-016-1693-7/tables/5

Metadata

Authors
Bravo-Venegas, J., Rodriguez-Siza, J., Vergara, M., Torres, M., Dickson, A., Toledo, J. R., Molina, M. C., Hermoso, M. A., Berríos, J., & Altamirano, C.
Affiliations
  • Pontificia Universidad Católica de Valparaíso (CL)
  • Pontificia Universidad Católica de Valparaíso
  • The University of Queensland (AU)
  • University of Manchester (GB)
  • University of Concepción (CL)
  • University of Chile (CL)
  • University of Groningen (NL)
Corresponding author
Torres, Mauro
Venue
mAbs
Published
2026-03-15
Volume
18
Issue
1
Pages
2643039-2643039
ISSN
  • 1942-0862 (ISSN-L)
  • 1942-0870
OpenAlex
W7136093066
Cited by
6
References
77
Citations by year
2026: 6
FWCI
8.76
Type
journal article
Language
en
Open access
Locations
  • mAbs (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research and Development Agency of Chile (FONDECYT 1241453, 1221031, ANILLO C&T ACT210068, FOVI22005, FOVI240154, FONDEF ID23I10018, ANID FONDEQUIP EQM 240055, ANID Scholarship 21232083, 21212223)
  • Biotechnology and Biological Sciences Research Council of the UK (BB/N004192/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Keywords
IgG glycosylation, process parameters, CHO cell culture, monoclonal antibodies, glycosylation heterogeneity, galactosylation, fucosylation, temperature effects, osmolality, pH, dissolved oxygen, partial pressure of CO2
MeSH terms
Animals, Antibodies, Monoclonal, Cricetulus, Glycosylation, Cricetinae, Humans, Hydrogen-Ion Concentration, Immunoglobulin G, Polysaccharides, Temperature, CHO Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis. https://app.cochat.ai/papers/10.1080/19420862.2026.2643039
The paper
Bravo-Venegas, J., Rodriguez-Siza, J., Vergara, M., Torres, M., Dickson, A., Toledo, J. R., Molina, M. C., Hermoso, M. A., Berríos, J., & Altamirano, C. (2026). Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis. mAbs. https://doi.org/10.1080/19420862.2026.2643039

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.